摘要
目的:观察特利加压素治疗肝肾综合征的疗效。方法:60例患者分为2组,在内科综合治疗基础上,A组使用特利加压素,B组为对照组,观察患者临床表现、实验室指标、转归等。结果:A组较B组平均动脉压增高、尿量增多、血Cr降低,有效率增加,差异有统计学意义。结论:特利加压素对肝肾综合征的治疗安全、有效。
AIM:To observe the effect of terlipressin in the management of patients with hepatorenal syndrome.METHODS:60 patients were divided into two groups.In Group A,terlipressine was used and Group B was control group.The clinical manifestation,laboratory examination,turnover were observed during treatment.RESULTS:Compared with Group B,the effective power,the mean arterial pressure and the total urine output were increased significantly,the serum creatinine level was decreased remarkably.CONCLUSION:Terlipressin is safe and effective on hepatorenal syndrome with minute adverse reaction.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2009年第10期1164-1167,共4页
Chinese Journal of Clinical Pharmacology and Therapeutics